Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed Aug 8, 2011 · 10-Q · 39 days after period end · 0001193125-11-214321
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Net Income | -$1.93M | -$3.58M |
| EPS Diluted | -$0.05 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 8, 2011 · 39 d after period end
